Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol. 2007;38(2):197–204. Article CAS PubMed Google Scholar Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. ...
Ductal carcinoma in-situ and BRCA-positive were the most common diagnoses, in 26 patients (30.9 %) each. The most common flaps used were the DIEP (77.6 %), transverse upper gracilis (7.5 %), profunda artery perforator (7.5 %), and superficial inferior epigastric artery flaps (3.7 %). An...
Ductal carcinoma in situ tumours were excluded because they are not systematically or consistently recorded by cancer registries. These are standard exclusion criteria designed to improve internal validity and consistency in population-based cancer survival studies. Full details of quality control procedures...
A total of 23 women with 24 cancers were enrolled, ranging in age from 32 to 76. One had ductal carcinoma in situ; there were 13 T1, 6 T2 and 4 T3 lesions. Nipple aspiration fluid was identified in 72 % of breasts, more commonly in cancerous than unaffected breasts. Ductal lavage wa...
The majority of patients (71%) were patients with infiltrating ductal carcinoma, 70% had advanced disease (Stage III), and in 51% of cases the tumour was more than 5 cm in size. Finally it was found that two-third of patients (76%) underwent modified radical mastectomy. Although this ...
1). Patients with ductal carcinoma in-situ (stage 0), metastatic disease (stage IV), recurrent breast cancer, unknown breast cancer subtype, or those who did not receive surgical treatment were excluded. Surgical treatment was considered an inclusion criteria as (1) most patients with stage I-...
Since the late 1990s, invasive mammary carcinomas have been classified into molecular subgroups through related gene expression levels [10,[16], [17], [18], [19]]. Ductal carcinoma in situ (DCIS) is defined as the growth of neoplastic cells that have not yet infiltrated the basal lamina ...
Prediagnostic circulating levels of sex steroid hormones and SHBG in relation to risk of ductal carcinoma in situ of the breast among UK women Cancer Epidemiol Biomarkers Prev, 29 (2020), pp. 1058-1066 CrossrefView in ScopusGoogle Scholar [40] T.V. Clendenen, W. Ge, K.L. Koenig, Y. ...
D05.00 -hyphen D05.92 Carcinoma in situ, breast [invasive and ductal carcinoma in situ (DCIS) is not included] D24.1 -hyphen D24.9 Benign neoplasm of breast [pseudo-hyphenangiomatous stromal hyperplasia (PASH) – not covered for prophylactic mastectomy] [atypical hyperplasia of lobular or ductal...
A negative margin was achieved at the first operation in 97 % of patients with invasive carcinoma and 97 % of patients with ductal carcinoma in-situ (DCIS). An additional 9 % of patients with invasive carcinoma and 19 % of patients with DCIS had close (less than or equal to 2 mm) ...